Zhuang, Wei
Lu, Mei
Wu, Ye
Chen, Zhehui
Wang, Minying
Wang, Xudong
Guan, Shaoxing
Lin, Wanlong http://orcid.org/0000-0002-0625-8155
Funding for this research was provided by:
National Natural Science Foundation of China (82304629)
Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515012549, 2023A1515012667)
Article History
Accepted: 25 October 2023
First Online: 23 November 2023
Declarations
:
: The authors have no relevant conflicts of interest to disclose. There is no financial/nonfinancial need to disclosures of all authors.
: The present pharmacovigilance study was conducted using a public database of spontaneous reports. Given the use of deidentified data, ethical approval was not considered necessary.
: The data are openly available in the FDA Adverse Event Reporting System Public Dashboard at: ExternalRef removed.
: FDA Adverse Event Reporting System is a spontaneous reporting system, the publicly available data are anonymized, and therefore, obtaining consent to participate is not applicable.
: Not applicable.
: The custom code used in this study have been made available upon request. Please contact Dr. Wei Zhuang (zhuangw8@mail.sysu.edu.cn) for access to the code.
: WZ performed the main data analysis and statistics work, and wrote this manuscript. ML participated a part of data mining, gave the constructive suggestion and revised this manuscript. YW, ZC, MW, XW and SG participated the data cleaning and analysis. WL designed this study, critically reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.